At CellOxess, our central goal is to transform the nutraceutical industry by establishing new standards in product design and manufacturing practices. We're focused on developing next-generation dietary supplements with superior safety and efficacy. The company’s research and development process is underpinned by a commitment to deliver novel products, guided by a scientific focus in redox biology and nutrient biochemistry. Our immediate priority is to address the global fertility decline with evidence-based, personalized preconceptual and prenatal supplements designed to achieve nutrient and redox homeostasis towards a healthy pregnancy and child.
Looking for a particular CellOxess employee's phone or email?
The CellOxess annual revenue was $18 million in 2026.
Parviz Gharagozloo is the President and CEO of CellOxess.
2 people are employed at CellOxess.
CellOxess is based in Ewing, New Jersey.
The NAICS codes for CellOxess are [32541, 325, 325413, 32, 3254].
The SIC codes for CellOxess are [28, 283].